By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Paris      France
Phone: n/a Fax: n/a


Medical Device

Company News
Nanobiotix Announces Submission For First Market Approval Of Lead Product NBTXR3 In Europe 9/14/2016 8:04:38 AM
Nanobiotix Half Year Results for the Six Months Ended 30 June 2016 8/31/2016 2:12:37 PM
Nanobiotix Revenue For Q2 2016 7/15/2016 9:22:27 AM
Nanobiotix Reports Successful Results From Phase I/II Trial Of NBTXR3 In Head & Neck Cancer 7/7/2016 8:36:11 AM
Nanobiotix Receives U.S. $1 Million Milestone Payment From PharmaEngine, Inc. 6/1/2016 8:53:13 AM
Nanobiotix Establishes Promising Preclinical Proof-Of-Concept In Immuno Oncology 5/31/2016 10:32:59 AM
Nanobiotix Starts A New Research Program, In Immuno Oncology, With Its Lead Product NBTXR3 1/5/2016 10:04:14 AM
Nanobiotix Release: FDA Approved Investigational New Drug For NBTXR3 In A New Clinical Study In Prostate Cancer 1/4/2016 10:47:58 AM
Nanobiotix Revenue For Q2 2015 7/15/2015 10:53:55 AM
Nanobiotix Reports Positive Preliminary Results In Head And Neck Cancer Phase I/II Clinical Trial With NBTXR3 6/9/2015 2:33:15 PM